Biography of Dominic Wall: Founder & CEO of Cell Therapies -Entrepreneur
Biography of Dominic Wall:
Dominic Wall is an accomplished executive specializing in
innovative healthcare ventures, with a career dedicated to advancing cell
therapy and cancer diagnostics. With over two decades of expertise, Dominic is
recognized for his leadership in complex medical and scientific fields,
transforming groundbreaking ideas into operational realities. He currently
serves as the Executive Director of Business Ventures at the Peter MacCallum
Cancer Centre, overseeing strategic partnerships and advanced medical services.
Foundational Role at Cell Therapies Pty Ltd
Dominic co-founded Cell Therapies Pty Ltd, a contract
development and manufacturing organization (CDMO) that produces cell and gene
therapies for global markets, including Australia, the US, the EU, and Asia. As
Chief Scientific Officer, he has been at the forefront of developing innovative
therapies like CAR-T cells, stem cell treatments, and regenerative medicine
products. He ensures compliance with international regulatory standards,
including approvals in regions such as Japan.
Biography of Dominic Wall: Founder & CEO of Cell Therapies -Entrepreneur#cell and gene therapies#startup#age#net worth#investor#Cell Therapies story
Ensuring Safety and Quality in Advanced Therapies
Dominic has final accountability for the safety and quality
of cell and gene products under TGA cGMP manufacturing licenses. His work
involves maintaining high-grade facilities, validating processes, and ensuring
regulatory compliance for clinical and commercial products. His expertise spans
trial development, sourcing therapeutic materials, and overseeing the
production of advanced medical therapies for human use.
Championing Cellular Immunotherapy
At Peter MacCallum Cancer Centre, Dominic leads the national
Centre of Excellence in Cellular Immunotherapy. This initiative, backed by an
$80 million government investment, focuses on cutting-edge cellular
immunotherapy technologies to combat cancer. Dominic’s leadership extends to
diagnostic pathology and specialized clinical trial services, enabling
groundbreaking cancer research and treatment advancements.
Extensive Experience in Pathology Operations
Previously, Dominic served as the Director of Pathology:
Operations at Peter Mac, managing diagnostic and scientific services for the
comprehensive cancer center. He oversaw a multidisciplinary team delivering
essential services like immunology, molecular pathology, and blood banking,
with a focus on innovation and quality assurance in medical diagnostics.
Regulatory Expertise in Cell Therapy
Dominic is a regulatory affairs specialist with extensive
experience in managing clinical trials and obtaining approvals for advanced
therapies. He has successfully completed numerous CMC chapters, trial
applications, and licensing processes in Australia, the US, Europe, and Asia.
His work ensures that new therapies meet stringent global standards for patient
safety and efficacy.
Academic and Professional Milestones
Dominic trained in pathology at the University of London and
earned his PhD from the University of Melbourne. He holds a Founding Fellowship
in Science from the Royal College of Pathologists of Australasia. His academic
grounding in immunology and flow cytometry underpins his technical expertise,
which is critical to advancing cell-based therapies.
Driving Innovation in CAR-T Manufacturing
Dominic’s contributions to CAR-T therapy manufacturing are
groundbreaking. He led the production of Australia’s first CAR-T products in
2008 and has since overseen advancements in gene-modified cell therapies. His
leadership has made Cell Therapies Pty Ltd a trusted name in cellular
immunotherapy, supporting both commercial and clinical innovations.
Governance and Industry Leadership
In addition to his executive roles, Dominic chairs the Legal
& Regulatory Subcommittee of the International Society for Cell Therapy
(ANZ). He has twice served as the regional president of this professional
society, demonstrating his commitment to advancing the global cell therapy
industry and fostering collaboration among experts.
Visionary in Transforming Healthcare
Dominic Wall’s career exemplifies a visionary approach to
specialized healthcare. His leadership, regulatory expertise, and dedication to
innovation have transformed cell therapy and cancer diagnostics, making
life-saving treatments accessible to patients worldwide. Through his pioneering
efforts, Dominic continues to shape the future of advanced medical therapies.
Timeline for story
2008: Produced Australia’s first CAR-T therapy products.
2010s: Co-founded Cell Therapies Pty Ltd, specializing in
cell and gene therapies.
2010s: Served as Director of Pathology: Operations at Peter
MacCallum Cancer Centre.
2018: Led establishment of the Centre of Excellence in
Cellular Immunotherapy with $80M funding.
2020s: Chaired the Legal & Regulatory Subcommittee of
the International Society for Cell Therapy (ANZ).
2020s: Oversaw CAR-T and regenerative medicine advancements
at Cell Therapies Pty Ltd.